[1]
|
Politis, M., Su, P. and Piccini, P. (2012) Imaging of Microglia in Patients with Neurodegenerative Disorders. Frontiers in Pharmacology, 3, Article 96.
https://doi.org/10.3389/fphar.2012.00096
|
[2]
|
Wei, J., Gambrusiewicz, K. and Heimberger, A. (2013) The Controversial Role of Microglia in Malignant Glioma. Clinical and Developmental Immunology, 2013, Article ID 285246. http://doi.org/10.1155/2013/285246
|
[3]
|
Tremblay, M.-E. and Majewska, A.K. (2011) A Role for Microglia in Synaptic Plasticity. Communicative and Integrative Biology, 4, 220-222.
https://doi.org/10.4161/cib.4.2.14506
|
[4]
|
Bechade, C., Cantaud-Belarif, Y. and Bessis, A. (2013) Microglial Control of Neuronal Activity. Frontiers in Cellular Neuroscience, 7, Article 32.
https://doi.org/10.3389/fncel.2013.00032
|
[5]
|
Schafer, D.P., Lehrmann, E.K. and Stevens, B. (2013) The “Quad-Partite” Synapse: Microglia-Synapse Interactions in the Developing and Mature CNS. GLIA, 61, 24-36. https://doi.org/10.1002/glia.22389
|
[6]
|
Neiva, I., Malva, J.O. and Valero, J. (2014) Can We Talk about Microglia without Neurons? A Discussion of Microglial Cell Autonomous Properties in Culture. Frontiers in Cellular Neuroscience, 8, Article 202.
https://doi.org/10.3389/fncel.2014.00202
|
[7]
|
Abud, E.M., Ramirez, R.N., Martinez, E.S., Healey, L.M., Nguyen, C.H.H., Newman, S.A., Yeromin, A.V., Scarfone, V.M., Marsh, E.M., Fimbres, C., Caraway, C.A., Fote, G.M., Madany, A.M., Agrawal, A., Kayed, R., Gylys, K.H., Cahalan, M.D., Cummings, G.M., Antel, J.P., Mortazavi, A., Carson, M.J., Poon, W.W. and Blurton-Jones, M. (2017) IPSC-Derived Human Microglia-Like Cells to Study Neurological Diseases. Neuron, 94, 278-293. https://doi.org/10.1016/j.neuron.2017.03.042
|
[8]
|
Kettenmann, H., Hanisch, U.-K., Noda, M. and Verkhratskii, A. (2011) Physiology of Microglia. Physiological Reviews, 91, 461-553.
https://doi.org/10.1152/physrev.00011.2010
|
[9]
|
Dudvarski-Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F. and Schmidt, M.H.H. (2016) Microclia-Blood Vessel Interactions: A Double Edged Sword in Brain Pathology. Acta Neuropathologica, 131, 347-363.
https://doi.org/10.1007/s00401-015-1524-y
|
[10]
|
Rovida, E. and Sbarba, P.D. (2015) Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? Journal of Clinical and Cellular Immunology, 6, 379.
https://doi.org/10.4172/2155-9899.1000379
|
[11]
|
Jacobs, A.H. and Tavitian, B. (2012) Noninvasive Molecular Imaging of Neuroinflammation. Journal of Cerebral Blood Flow & Metabolism, 32, 1393-1415
https://doi.org/10.1038/jcbfm.2012.53
|
[12]
|
Jung, S., Alberti, J., Graemmel, P., Sunshine, M.J., Kreutzberg, G.W., Sher, A. and Littman, D.R. (2000) Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion. Molecular & Cellular Biology, 20, 4106-4114.
https://doi.org/10.1128/MCB.20.11.4106-4114.2000
|
[13]
|
Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., Littman, D.R., Dustion, M.L. and Gan, W.-B. (2005) ATP Mediates Rapid Microglial Response to Local Brain Injury In Vivo. Nature Neuroscience, 8, 752-758.
https://doi.org/10.1038/nn1472
|
[14]
|
Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) Resting Microglial Cells are Highly Dynamic Surveillants of Brain Parenchyma In Vivo. Science, 308, 1314-1319
https://doi.org/10.1126/science.1110647
|
[15]
|
Gaikwad, S.M. and Heneka M.T. (2013) Studying M1 and M2 State in Adult Microglia. In: Joseph, B. and Venero, J.L., Eds., Microglia: Methods and Protocols, Methods in Molecular Biology, Vol. 1041, © Springer Science+Business Media, New York, 185-197. https://doi.org/10.1007/978-1-62703-520-0_18
|
[16]
|
Burguillos, M.A. (2013) Use of Mesoscale Discovery to Examine Cytokine Content in Microglial Cell Supernatant. In: Joseph, B. and Venero, J.L., Eds., Microglia: Methods and Protocols, Methods in Molecular Biology, Vol. 1041, © Springer Science+Business Media, New York, 93-100.
https://doi.org/10.1007/978-1-62703-520-0_11
|
[17]
|
Mildner, A. (2017) Ghost in the Shell: Identification of Microglia in the Human Central Nervous System by P2Y12 Receptor. Neural Regeneration Research, 12, 570-571. https://doi.org/10.4103/1673-5374.205090
|
[18]
|
Lawson, L.J., Perry, V.H., Dri, P. and Gordon, S. (1990) Heterogeneity in the Distribution and Morphology of Microglia in the Normal Adult Mouse Brain. Neuroscience, 39, 151-170. https://doi.org/10.1016/0306-4522(90) 90229-W
|
[19]
|
Gehrmann, J., Matsumoto, Y. and Kreutzberg, G.W. (1995) Intrinsic Immuneffector Cell of the Brain. Brain Research Reviews, 20, 269-287.
https://doi.org/10.1016/0165-0173(94) 00015-H
|
[20]
|
Hambarzumyan, D., Gutmann, D.H. and Kettenmann H. (2016) The Role of Microglia and Macrophages in Glioma Maintenance and Progression. Nature Neuroscience, 19, 20-27. https://doi.org/10.1038/nn.4185
|
[21]
|
Haenseler, W., Sansom, S.N., Buchrieser, J., Newey, S.E., Moore, C.S., Nicholls, F.J., Chintawar, S., Schnell, C., Antel, J.P., Allen, N.D., Cader, M.Z., Wade-Martins, R., James, W.S. and Coley, S.A. (2017) A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal Co-Culture Specific Expression Profile and Inflammatory Response. Stem Cell Reports, 8, 1727-1747.
https://doi.org/10.1016/j.stemcr.2017.05.017
|
[22]
|
Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S.E.W., Pollard, J.W., Frampton, J., Liu, K.J. and Geissmann, F. (2012) A Lineage of Myeloid Cells Independent of Myb and Hamatopoetic Stem Cells. Science, 336, 86-90.
https://doi.org/10.1126/science.1219179
|
[23]
|
Ginhoux, F. and Prinz, M. (2015) Origin of Microglia: Current Concepts and Past Controversies. Cold Spring Harbor Perspective in Biology, 7, a020537.
https://doi.org/10.1101/cshperspect.a020537
|
[24]
|
Eyo, U.B. and Wu, L.J. (2013) Bidirectional Microglia-Neuron Communication in the Healthy Brain. Neural Plasticity, 2013, Article 456857.
https://doi.org/10.1155/2013/456857
|
[25]
|
Gomes-Leal, W. (2013) Microglial Physiopathology: How to Explain the Dual Role of Microglia after Acute Neural Disorders? Brain and Behavior, 2, 345-356.
https://doi.org/10.1002/brb3.51
|
[26]
|
Boche, D., Perry, V.H. and Nicoll, A.R. (2013) Review: Activation Patterns of Microglia, and Their Identification in the Human Brain. Neuropathology and Applied Neurobiology, 39, 3-18. https://doi.org/10.1111/nan.12011
|
[27]
|
Basile, A. and Skolnick, P. (1986) Subcellular Localization of “Peripheral-Type” Binding Sites for Benzodiazepines in Rat Brain. Journal of Neurochemistry, 46, 305-308. https://doi.org/10.1111/j.1471-4159.1986.tb12965.x
|
[28]
|
Wohleb ES. (2016) Neuron Microglia Interactions in Mental Health Disorders: “For Better, and for Worse”. Frontiers in Immunology, 7, Article 544.
https://doi.org/10.3389/fimmu.2016.00544
|
[29]
|
Garcia, J.A., Cardona, S.M. and Cardona, A.E. (2013) Chapter 27: Analysis of Microglia Effector Function Using CX3CR1-GFP-Knock in Mice. In: Joseph, B. and Venero, J.L., Eds., Microglia: Methods and Protocols, Methods in Molecular Biology, Vol. 1041, © Springer Science+Business Media, New York, 307-317.
|
[30]
|
Tronel, C., Largeau, B., Ribeiro, M.J.S., Guilloteau, D., Dupont, A.-C. and Arlicot, N. (2017) Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations. International Journal of Molecular Sciences, 18, 802. https://doi.org/10.3390/ijms18040802
|
[31]
|
Veenman, L., Alten, J., Linnemanstons, K., Shandalov, Y., Zeno, S., Lakomek, M., Gavish, M. and Kugler, W. (2010) Potential Involvement of F0F1-ATP(synth) ase and Reactive Oxygen Species in Apoptosis Induction by the Antineoplastic Agent Erucylphosphohomocholine in Glioblastoma Cell Lines: A Mechanism for Induction of Apoptosis via the 18 kDa Mitochondrial Translocator Protein. Apoptosis, 15, 753-768. https://doi.org/10.1007/s10495-010-0460-5
|
[32]
|
Krestinina, O.V. Grachev, D.E., Odinokova, D.E., Reiser, G., Evtodienlo, Yu.V. and Azarashvili, T.S. (2009) Effect of Peripheral Benzodiazepine Receptor (PBR/TSPO) Ligands on Opening of Ca2+-Induced Pore and Phosphorylation of 3.5-kDa Polypeptide in Rat Brain Mitochondria. Biochemistry (Moscow), 74, 421-429.
https://doi.org/10.1134/S0006297909040105
|
[33]
|
Jaremko, L., Jaremko, M., Giller, K., Becker, S. and Zweckstetter, M. (2014) Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand. Science, 343, 1363-1366. https://doi.org/10.1126/science.1248725
|
[34]
|
Denora, N., Jacobazzi, R.M., Natile, G and Margiotta, N. (2017) Metal Complexes Targeting the Translocator Protein (18 kDa) (TSPO). Cooordination Chemistry Reviews, 341, 1-18. https://doi.org/10.1016/j.ccr.2017.03.023
|
[35]
|
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D. and Schumacher, M. (2010) Translocator Protein (18 kDa) (TSPO) as a Therapeutic Target for Neurological and Psychiatric Disorders. Nature Reviews Drug Discovery, 9, 971-988. https://doi.org/10.1038/nrd3295
|
[36]
|
Fan, Z., Calsolaro, V., Atkinson, R.A., Femminella, G.D., Waldman, A., Buckley, C., Trigg, W., Brooks, D.J., Hinz, R. and Edison. P. (2016) Flutriciclamide [18F-GE180] PET: First in Human PET Study of Novel 3rd Generation In Vivo Marker of Human Translocator Protein. Journal of Nuclear Medicine, 57, 1753-1759.
https://doi.org/10.2967/jnumed.115.169078
|
[37]
|
Liu, G.-J., Middleton, R.J. and Banati, R.B. (2017) Subcellular Distribution of the 18 kDA Translocator Protein and Transcript Variant PBR-S in Human Cells. Gene, 613, 45-56. https://doi.org/10.1016/j.gene.2017.02.035
|
[38]
|
Li, F., Liu, N., Kuhn, L.A., Garavito, R.M., Ferguson-Miller, S. (2016) Translocator Protein 18 kDa (TSPO): An Old Protein with New Functions? Biochemistry, 55, 2821-2831. https://doi.org/10.1021/acs.biochem.6b00142
|
[39]
|
Jaremko, M., Jaremko, L., Jaipuria, G., Becker, S. and Zweckstetter, M. (2015) Structure of the Mammalian TSPO/PBR Protein. Biochemical Society Transactions, 43, 566-571. https://doi.org/10.1042/BST20150029
|
[40]
|
Jaipuria, G., Leonov, A., Giller, K., Kumar Vasa, S., Jaremko, L., Jaremko, M., Linser, R., Becker, S. and Zweckstetter, M. (2017) Cholesterol-Mediated Allosteric Regulation of the Mitochondrial Translocator Protein Structure. Nature Communications, 8, 14893, https://doi.org/10.1038/ncomms14893
|
[41]
|
Shoshan-Barmatz, V., Ben-Hail, D., Admoni, L., Krelin, Y. and Sharan Tripathi, S. (2025) The Mitochondrial Voltage Dependent Anion-Channel 1 in Tumor Cells. Biochimica et Biophysica Acta (BBA)—Biomembranes, 1848, 2547-2575.
https://doi.org/10.1016/j.bbamem.2014.10.040
|
[42]
|
Banati, R.B., Middelton, R.J., Chan, R., Hatty, C.R., Wai-Ying Kam, W., Quin, C., Graeber, M.B., Parma, A., Zahra, D., Callaghan, P., Fok, S., Howell, N.R., Gregoire, M., Szabo, A., Pham, T., Davis, E. and Liu, G.-J. (2014) Positron Emission Tomography and Functional Characterization of a Complete PBR/TSPO Knockout. Nature Communications, 5, 5452. https://doi.org/10.1038/ncomms6452
|
[43]
|
Guilarte, T.R., Loth, M.K., Guariglia, S.R. (2016) TSPO Finds NOX2 in Microglia for Redox Homeostasis. Trends in Pharmacological Sciences, 37, 334-343.
https://doi.org/10.1016/j.tips.2016.02.008
|
[44]
|
Lartey, F.M., Ahn, G.-O., Ali, R., Rosenblum, S., Miao, Z., Arksey, N., Shen, B., Colomer, M.V., Rafat, M., Liu, H., Alejandre-Alcazar, M.A., Chem, J.W., Palmer, T., Chin, F.T., Guzman, R., Loo Jr., B.W. and Graves E. (2014) The Relationship between Serial [18F]PBR06 PET Imaging of Microglial Activation and Motoric Function Following Stroke in Mice. Molecular Imaging and Biology, 16, 821-829.
https://doi.org/10.1007/s11307-014-0745-0
|
[45]
|
Jones, B.A., Beamer, M. and Ahmed, S. (2010) Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases. Molecular Interventions, 10, 263-270.
https://doi.org/10.1124/mi.10.5.3
|
[46]
|
Corona, A.W., Huang, Y., O’Connor, J.C., Dantzer, R, Kelley, K.W., Popovich, P.G. and Godbout, J.P. (2010) Fractalkine Receptor CX3CR1 Deficiency Sensitizes Mice to the Behavioral Changes Induced by Lipopolysaccaride. Journal of Neuroinflammation, 7, 93. https://doi.org/10.1186/1742-2094-7-93
|
[47]
|
Poniatowski, L.A., Woidasiewicz, P., Krawzyk, M., Sziukiewicz, D., Gasik, R., Kubaszewski, L. and Kurkowska-Jastrzebska, I. (2017) Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. Molecular Neurobiology, 54, 2167-2188. https://doi.org/10.1007/s12035-016-9787-4
|
[48]
|
MacDowell, K.S., Caso, J.R., Martín-Hernández, D., Moreno, B.M., Madrigal, J.L.M., Micó, J.A., Leza, J.C. and García-Bueno, B. (2016) The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress. Neurotherapeutics, 13, 833-843. https://doi.org/10.1007/s13311-016-0438-2
|
[49]
|
Bazan, J.F., Bacon, H.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Zlotnik, A. and Schall, T.J. (1997) A New Class of Membrane Bound Chemokine with a CX3C Motif. Nature, 385, 640-644. https://doi.org/10.1038/385640a0
|
[50]
|
Mizoue, L.S., Sullivan, S.K., King, D.S., Kledal, T.N., Schwartz, T.W., Bacon, K.B. and Handel, T.M. (2001) Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine. The Journal of Biological Chemistry, 276, 33906-33914. https://doi.org/10.1074/jbc.M101348200
|
[51]
|
Roumen, L., Scholten, D.J., de Kruijf, P., de Esch, I.J.P., Leurs, R. and de Graaf, C. (2012) Computer-Aided Prediction of Chemokine Receptor—Ligand Interactions. Drug Discovery Today: Technologies, 9, e281-e291.
https://doi.org/10.1016/j.ddtec.2012.05.002
|
[52]
|
Mease, R., Yang, X., Foss, C. and Pomper, M. (2015) Radiosynthesis and Initial In Vivo Evaluation of 2-18F-FBTTP, a Radiotracer Targeting CX3CR1. Journal of Nuclear Medicine, 56, 356.
|
[53]
|
Arimont, M., Sun, S.-L., Leurs, R., Smit, M., de Esch, I. J. P. and de Graaf, C. (2017) Structural Analysis of Chemokine Receptor-Ligand Interactions. Journal of Medicinal Chemistry, 60, 4735-4779. https://doi.org/10.1021/acs.jmedchem.6b01309
|
[54]
|
Gent, Y.Y.J., Weijer, K., Molthoff, C.F.M., Windhorst, A.D, Huisman, M.C., Smith, D.E.C., Kularatne, S.A., Jansen, G., Low, P.S., Lammertsma, A.A. and van der Laken, C.J. (2013) Evaluation of the Novel Folate Receptor Ligand [18F]Fluoro-PEG-Folate for Macrophage Targeting in a Rat Model of Arthritis. Arthritis Research and Therapy, 15, R37.
|
[55]
|
Al Jammaz, I., Al-Otaibi, B., Al-Rumayan, F., Al-Yanbawi, S., Amer, S. and Okarvi, S.M. (2014) Development and Preclinical Evaluation of 124I-Folate Conjugates for PET Imaging of Folate-Receptor Positive Tumors. Nuclear Medicine and Biology, 41, 457-463. https://doi.org/10.1016/j.nucmedbio.2014.03.013
|
[56]
|
Chen, Q., Meng, X., McQuade, P., Rubin, D., Lin, S.-A., Zeng, Z., Haley, H., Miller, P., Trotter, D.G. and Low, P.S. (2016) Synthesis and Preclinical Evaluation of NOTA-Al18F for PET Imaging. Molecular Pharmaceutics, 13, 1520-1527.
https://doi.org/10.1021/acs.molpharmaceut.5b00989
|
[57]
|
Wibowo, A., Singh, M., Reeder, K.M., Carter, J.J., Kovach, A.R., Meng, W., Ratnam, M., Zhang, F. and Dann, C.E. (2013) Structures of Human Folate Receptors Reveal Biological Trafficking States and Diversity in Folate and Antifolate Recognition. Proceedings of the National Academy of Sciences, 110, 15180-15188.
https://doi.org/10.1073/pnas.1308827110
|
[58]
|
Chen, C., Ke, J., Zhou, E., Ji, W., Brunzelle, J.S., Li, J., Yong, E.-L., Xu, H.E. and Melcher, K. (2013) Structural Basis for Molecular Recognition of Folic Acid by Folate Receptors. Nature, 500, 486-490. https://doi.org/10.1038/nature12327
|
[59]
|
Müller, C. (2013) Folate-Based Radiotracer for PET Imaging-Update and Perspectives. Molecules, 18, 5005-5031. https://doi.org/10.3390/molecules18055005
|
[60]
|
Gavish, M. Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G. and Weizman, W. (1999) Enigma of the Peripheral Benzodiazepine Receptor. Pharmacological Reviews, 51, 629-650.
|
[61]
|
Venneti, S. Lopreti, B.J., Wiley, C.A. (2013) Molecular Imaging of Microglia/Macrophages in the Brain. GLIA, 61, 10-23. https://doi.org/10.1002/glia.22357
|
[62]
|
Anholt, R.R., De Souza, E.B., Oster-Granite, M.L. and Snyder, S.H. (1985) Peripheral-Type Benzodiazepine Receptors: Autoradiographic Localization in Whole-Body Sections of Neonatal Rats. Journal of Pharmacology and Experimental Therapeutics, 233, 517-526.
|
[63]
|
LeFur, G., Perrier, M.L., Vaucher, N., Imbault, F., Flamier, A., Benavides, J., Uzan, A., Renault, C., Dubroeuq, M.C. and Guérémy, C. (1983) Peripheral Benzodiazepine Binding Sites: Effect of PK11195 (1-(2-Chlorophenyl)-N-Methyl-N-(1-Methylpropyl)-3-Isoquinoline Carboxamide: I. In Vitro Studies. Life Science, 32, 1839-1847.
https://doi.org/10.1016/0024-3205(83) 90062-0
|
[64]
|
Syapin, P.J. and Skolnick, P. (1979) Characterization of Benzodiazepine Binding Sites in Cultured Cells of Neural Origin. Journal of Neurochemistry, 32, 1047-1051.
https://doi.org/10.1111/j.1471-4159.1979.tb04592.x
|
[65]
|
Marangos, P.J., Patel, J., Boulenger, J.-P. and Clark-Rosenberg, R. (1982) Characterization of Peripheral-Type Benzodiazepine Binding Sites in Brain Using [3H]Ro5-4864. Molecular Pharmacology, 22, 26-32.
|
[66]
|
Marginedas-Freixa, I., Hattab, C., Bouyer, G., Halle, F., Chene, A., Lefevre, S.D., Cambot, M., Cueff, A., Schmitt, M., Gamain, B., Lacapere, J.J., Egee, S., Bihel, F., Le Vam Kim, C. and Ostuni, M.A. (2016) TSPO Ligands Stimulate ZnPPIX and ROS Accumulation Leading to the Inhibition of P. Falciparum Growth in Human Blood. Scientific Reports, 6, Article 33516. https://doi.org/10.1038/srep33516
|
[67]
|
Bernardi, P. and Di Lisa, F. (2015) The Mitochondrial Permeability Transition Pore: Molecular Nature and Role as a Target in Cardioprotection. Journal of Molecular and Cellular Cardiology, 78, 100-106. https://doi.org/10.1016/j.yjmcc.2014.09.023
|
[68]
|
Fancelli, D., Abate, A., Amici, R., Bernardi, P., Ballarini, M., Cappa, A., Carezi, G., Colombo, C., Di Lisa, F., Dondio, G., Gagliardi, S., Milanesi, E., Minucci, S., Pain, G., Pelicci, P.G., Saccani, A., Storto, M., Thaler, F., Varasi, M., Vill, A.M. and Plyte, S. (2014) Cinnamic Anilides as New Mitochondrial Permeability Transition Pore Inhibitors Endowed with Ischemia-Reperfusion Injury Protective Effect In Vivo. Journal of Medicinal Chemistry, 57, 5333-5347. https://doi.org/10.1021/jm500547c
|
[69]
|
Elustondo, P.A., Nichols, M., Negoda, A., Thirumaran, T., Zakharian, E., Robertson, G.S. and Pavlov, E.V. (2016) Mitochondrial Permeability Transition Pore Induction Is Linked to Formation of the Complex of ATPase C-Subunit, Polyhydroxybutyrate and Inorganic Polyphosphate. Cell Death Discovery, 2, 16070.
https://doi.org/10.1038/cddicovery.2016.70
|
[70]
|
Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B. and Midzak, A. (2015) Translocator Protein-Mediated Pharmacology of Cholesterol Transport and Steroidogenesis. Molecular and Cellular Endocrinology, 408, 90-98.
https://doi.org/10.1016{j.mce.2015.03.014
|
[71]
|
Bernardi, P., Rasola, A., Forte, M., and Lippe, G. (2015) The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology. Physiological Reviews, 95, 1111-1155. https://doi.org/10.1152/physrev.00001.2015
|
[72]
|
Yasin, N., Veenman, L., Singh, S., Azrad, L., Bode, J. and Vainstein, A., Caballero, B., Marek, I. and Gavish, M. (2017) Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression. Implications for Mitochondrial Retrograde Signaling. International Journal of Molecular Sciences, 18, 786. https://doi.org/10.3390/ijms18040786
|
[73]
|
Zhang, J. (2015) Mapping Neuroinflammation in Frontotemporal Dementia with Molecular PET Imaging. Journal of Neuroinflammation, 12, 108.
https://doi.org/10.1186/s12974-015-0236-5
|
[74]
|
Guo, Q., Owen, W.R., Rabiner, E.A., Turkheimer, F.E. and Gunn, R.N. (2012) Identifying Improved TSPO PET Imaging Probes through Biomathematics: The Impact of Multiple TSPO Binding Site In Vivo. Neuroimage, 60, 902-910.
https://doi.org/10.1016/j.neuroimage.2011.12.078
|
[75]
|
Srivasta, P., Kaul, A., Ojha, H., Kumar, P., Tiwari, A.K. (2016) Design, Synthesis and Biological Evaluation of Methyl-2-(2-(5-Bromo-Benzoxazolone) Acetamido)-3-(1H Indol-3-yl) Propanoate: TSPO Ligand for SPECT. RSC Advances, 6, 1114491.
https://doi.org/10.1039/C6RA19514H
|
[76]
|
Braestrup, C., Albrechtsen, R. and Squires, R.F. (1977) High Densities of Benzodiazepine Receptors in Human Cortical Areas. Nature, 269, 702-704.
https://doi.org/10.1038/269702a0
|
[77]
|
Braestrup, C. and Squires, R.F. (1977) Specific Benzodiazepine Receptors in Rat Brain Characterized by High-Affinity (3H) Diazepam Binding. Proceedings of the National Academy of Sciences, 74, 3805-3809.
https://doi.org/10.1073/pnas.74.9.3805
|
[78]
|
Awad, M. and Gavish, M. (1991) Peripheral-Type Benzodiazepine Receptors in Human Cerebral Cortex, Kidney, and Colon. Life Sciences, 49, 1155-1161.
https://doi.org/10.1016/0024-3205(91) 90562-P
|
[79]
|
Scarf, A.M. and Kassiou, M. (2011) The Translocator Protein. Journal of Nuclear Medicine, 52, 677-680. https://doi.org/10.2967/jnumed.110.086629
|
[80]
|
Airas, L., Rissanen, E. and Rinne, J.O. (2015) Imaging Neuroinflammation in Multiple Sclerosis Using TSPO PET. Clinical and Translational Imaging, 3, 461-473.
https://doi.org/10.1007/s40336-015-0147-6
|
[81]
|
Price, G.W., Ahier, R.G., Hume, S.P., Myers, R. and Manjil, L. and Cremer, J.E., Luthra, S.K., Pascali, C., Pike, V. and Frackowiak, R.S.J. (1990) In Vivo Binding to Peripheral Benzodiazepine Binding Sites in Lesioned Rat Brain: Comparison between [3H]PK11195 and [18F]PK14105 as Markers for Neuronal Damage. Journal of Neurochemistry, 55, 175-185. https://doi.org/10.1111/j.1471-4159.1990.tb08836.x
|
[82]
|
Beurdeley-Thomas, A., Miccoli, L., Oudard, S., Dutrillaux, B. and Poupon, M.F. (2000) The Peripheral Benzodiazepine Receptor: A Review. Journal of Neuro-Oncology, 46, 45-56. https://doi.org/10.1023/A:1006456715525
|
[83]
|
Henkel, K., Karitzky, J., Schmid, M., Mader, I., Glatting, G., Unger, J.W., Neumaier, B., Ludolph, A.C., Reske, S.N. and Landwehrmeyer, G.B. (2004) Imaging of Activated Microglia and [11C]PK11195 in Corticobasal Degeration. Movement Disorders, 19, 817-824. https://doi.org/10.1002/mds.20040
|
[84]
|
Scott, G., Hellyer, P.J., Ramlackhansingh, A.F., Brooks, D.J., Maths, P.M. and Sharp, D.J. (2015) Thalamic Information after Brain Trauma is Associated with Thalamo Cortical White Matter Damage. Journal of Neuroinflammation, 12, 224.
https://doi.org/10.1186/s12974-015-0445-y
|
[85]
|
Declercq, L.D., Vandenberghe, R., van Laere, K., Verbruggen, A. and Bormans, G. (2016) Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT. Frontiers in Pharmacology, 7, Article 88.
https://doi.org/10.3389/fphar.2016.00088
|
[86]
|
Doorduin, J., Klein, H.C., Dierckx, R.A., James, M., Kassiou, M. and de Vries, E.F.J. (2009) [11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO. A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis. Molecular Imaging and Biology, 11, 386-398. https://doi.org/10.1007/s11307-009-0211-6
|
[87]
|
Varrone, A., Mattsson, P., Forsberg, A., Takano, A., Nag, S., Gulyas, B., Borg, J., Boellaard, R., Al-Tawil, N., Eriksdotter, M., Zimmermann, T., Schultze-Mosgau, M., Thiele, A., Hoffmann, A., Lammertsma, A.A. and Halldin, C. (2013) In Vivo Imaging of the 18 kDa Translocator Protein (TSPO] with [18F]FEDAA1106 and PET Does Not Show Increased Binding in Alzheimer’s Disease Patients. European Journal of Nuclear Medicine and Molecular Imaging, 40, 921-931.
https://doi.org/10.1007/s00259-013-2359-1
|
[88]
|
Mabrouk, R., Strafella, A.P., Knezevic, D., Ghadery, C., Mizrahi, R., Gharegazlou, A., Koshimori, Y., Houle, S. and Rusjan, P. (2017) Feasibility Study of TSPO Quantification with [18F]FEPPA Using Population-Based Input Function. PLoS ONE, 12, e0177785. https://doi.org/10.1371/journal.pone.0177785
|
[89]
|
Suridjan, I., Rusjan, P.M., Voineskos, A.N., Selvanathan, T., Setiawan, E., Strafella, A.P., Wilson, A.A., Meyer, J.H., Houle, S. and Mizrahi, R. (2014) Neuroinflammation in Healthy Aging: A PET Study Using a Novel Translocator Protein 18kDa (TSPO) Radioligand, [18F] FEPPA. Neuroimage, 84, 868-875.
https://doi.org/10.1016/j.neuroimage.2013.09.021
|
[90]
|
Suridjan, I., Pollock, B.G., Verhoeff, N.P.L.G., Voineskos, A.N., Chow, T., Rusjan, P.M., Lobaugh, N.J., Houle, S., Mulsant, B.H. and Mizrahi, R. (2015) In Vivo Imaging of Grey and White Matter Neuroinflammation of Alzheimer’s Disease: Positron Emission Tomography Study with a Novel Radioligand [18F]FEPPA. Molecular Psychiatry, 20, 1579-1587. https://doi.org/10.1038/mp.2015.1
|
[91]
|
Koshimori, Y., Ko, J.-H., Mizrahi, R., Rusjan, P., Mabrouk, R., Jacobs, M.F. Christopher, L., Hamani, C., Lang, A.E., Wilson, A.A., Houle, S. and Strafella, A.P. (2015) Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease. PLoS ONE, 10, e0138721. https://doi.org/10.1371/journal.pone.0138721
|
[92]
|
Mueller-Gaertner, H.W., Links, J.M., Prince, J.L., Bryan, R.N., McVeigh, E., Leal, J.P., Davazikos, Ch. and Frost, J. (1992) Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects. Journal of Cerebral Blood Flow & Metabolism, 12, 571-583. https://doi.org/10.1038/jcbfm.1992.81
|
[93]
|
Venneti, S., Wang, G., Nguyen, J. and Wiley, C.A. (2008) The Positron Emission Tomography Ligand DAA1106 Binds with High Affinity to Activated Microglia in Human Neurological Disorders. Journal of Neuropathology & Experimental Neurology, 67, 1001-1010. https://doi.org/10.1097/NEN.0b013e318188b204
|
[94]
|
Mirzaei, N., Tang, S.P., Asworth, S., Coello, C., Plisson, C., Passchier, J., Selvaraj, V., Tyacke, R.J., Nutt, D.J. and Sastre, M. (2016) In Vivo Imaging of Microglial Activation by Positron Emission Tomography with [11C]PBR28 in the 5XFAD Model of Alzheimer Disease. GLIA, 64, 993-1006.
|
[95]
|
Wadsworth, H., Jones, P.A., Chau, W.-F., Durrant, C., Fouladi, N., Passmore, J., O’Shea, D., Wynn, D., Morrison-Iveson, V., Ewan, A., Thaning, M., Mantzilas, D., Gausemel, I., Khan, I., Black, A., Avory, M. and Trigg, W. (2012) [18F]GE-180: A Novel Fluorine 18 Labelled PET Tracer for Imaging Translocator Protein 18 kDa (TSPO). Bioorg and Medicinal Chemistry Letters, 22, 1308-1313.
https://doi.org/10.1016/j.bmcl.2011.12.084
|
[96]
|
Chau, W.-F., Black, A.M.A., Clarke, A., Durrant, C., Gausemel, I., Khan, I., Mantzilas, D., Oulie, I., Rogstad, A., Trigg, W. and Jones, P.A. (2015) Exploration of the Impact of Stereochemistry on the Identification of the Novel Translocator Protein PET Imaging Agent [18F]GE180. Nuclear Medicine and Biology, 42, 711-719.
https://doi.org/10.1016/j.nucmedbio.2015.05.004
|
[97]
|
Feeney, C., Scott, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A.P., Brooks, D.J., Nicholas, R.S., Trigg, W., Gunn, R.N. and Sharp, D.J. (2016) Kinetic Analysis of the Translocator Protein Positron Emission Tomography Ligand [18F]GE-180 in the Human Brain. European Journal of Nuclear Medicine and Molecular Imaging, 43, 2201-2210. https://doi.org/10.1007/s00259-016-3444-z
|
[98]
|
Owen, D.R., Guo, Q., Kalk, N.J., Colasanti, A., Kalogiannopoulou, D., Dimber, R., Lewis, Y.L., Libri, V., Barletta, J., Ramada-Magalhaes, J., Kamalakaran, A., Nut, D.J., Passchier, J., Matthews, P.M., Gunn, R.N. and Rabiner, E.A. (2014) Determination of [11C]PBR28 Binding Potential In Vivo: A First Human TSPO Blocking Study. Journal of Cerebral Blood Flow & Metabolism, 34, 989-994.
https://doi.org/10.1038/jcbfm.2014.46
|
[99]
|
Lassen, N.A., Bartenstein, P.A., Lammertsma, A.A., Prevett, M.C. Turton, D.R., Luthra, S.K., Osman, S., Bloomfield, P.M., Jones, T., Patsalos, D.R., Connell, T.O., Duncan, J.S. and Andersen, V. (1995) Benzodiazepine Receptor Quantification In Vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady State Principle. Journal of Cerebral Blood Flow & Metabolism, 15, 152-165.
https://doi.org/10.1038/jcbfm.1995.17
|
[100]
|
Okubo, T., Yoshikawa, R., Chaki, S., Okuyama, S. and Nakatzato, A. (2004) Design, Synthesis and Structure-Activity Relationships of Novel Tetracyclic Compounds as Peripheral Benzodiazepine Receptor Ligands. Bioorganic & Medicinal Chemistry, 12, 3569-3580. https://doi.org/10.1016/j.bmc.2004.04.025
https://doi.org/10.1016/j.bmc.2003.10.050
|
[101]
|
O’Shea, D., Ahmad, R., Arstad, E., Avory, M., Chau, W.F., Durrant, C., Hirani, E., Jones, P.A., Khan, I., Luthra, S.K., Mantzilas, D., Morrison-Iveson, V., Passmore, J., Robins, E.G., Shan, B., Wadsworth, H., Walton, S., Zhao, Y. and Trigg, W. (2013) Exploration of the Structure Activity Relationship of a Novel Tetracyclic Class of TSPO Ligands-Potential Positron Emitting Tomography Imaging Agents. Bioorganic & Medicinal Chemistry Letters, 23, 2368-2372.
https://doi.org/10.1016/j.bmcl.2013.02.057
|
[102]
|
Ikawa, M., Lohith, T.G., Shrestha, S., Telu, S., Zoghbi, S.S., Castellano, S., Taliani, S., da Settimo, F., Fujita, M., Pike, V.W. and Innis, R.B. (2017) 11C-ER176, a Radioligand 18 kDa Translocator Protein (TSPO) Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain. Journal of Nuclear Medicine, 58, 320-325.
|
[103]
|
Andrews, S.P. and Cox, R.J. (2016) Small Molecule CXCR Antagonists. Journal of Medicinal Chemistry, 59, 2894-2917.
https://doi.org/10.1021/acs.jmedchem.5b01337
|
[104]
|
Pawing, L., Klasen, C., Weber, C., Bernhagen, J. and Noels, H. (2015) Diversity and Inter-Connections in the CXCR4 Receptor/Ligand Family: Molecular Perspectives. Frontiers in Immunology, 6, Article 429.
|
[105]
|
Cederblad, L., Rosengren, B., Ryberg, E. and Hermansson, N.-O. (2016) AZD8797 is an Allosteric Non-Competitive Modulator of the Human CX3CR1 Rreceptor. Biochemical Journal, 473, 641-647. https://doi.org/10.1042/BJ20150520
|
[106]
|
Bachelerie, F., Ben-Baruch, A., Burkhardt, A.M., Combadiere, C., Farber, J.M., Graham, G.J., Goruk, R. Sparre-Ulrich, A.H., Locati, M., Luster, A.D., Matovani, A., Matsushima, K., Murphy, P.M., Nibbs, R., Nomiyama, H., Power, C.A., Proudfoot, A.E.I., Rosenkilde, M.M., Rot, A., Sozzani, S., Thelen, M., Yoshie, O. and Zlotnik A. (2014) International Union of Basic and Clinical Pharmacology LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors. Pharmacological Reviews, 66, 1-79.
https://doi.org/10.1124/pr.113.007724
|
[107]
|
Harrison, J.K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R.K., Streit, W.J., Salafranca, M.N., Adhikari, S., Thompson, D.A., Botti, P., Bacon, K.B. and Feng, L. (1998) Role for Neuronally Derived Fractalkine in Mediating Interactions Between Neurons and CX3CR1-Expressing Microglia. Proceedings of the National Academy of Sciences, 95, 10896-10901. https://doi.org/10.1073/pnas.95.18.10896
|
[108]
|
Wolf, Y., Yona, S., Kim, K.-W. and Jung, S. (2013) Microglia Seen from the CX3CR. Frontiers in Cellular Neuroscience, 7, Article 26.
|
[109]
|
Karlstrom, S., Nordvall, G., Sohn, D., Hettman, A., Turek, D., Ahlin, K., Kers, A., Claesson, M., Slivo, C., Lo-Alfredsson, Y., Petersson, C., Bessidskaia, G., Svensson, P.H., Rein, T., Jerning, E., Malmberg, A., Ahlgen, C., Ray, C., Vares, L., Ivanov, V. and Johansson, R. (2013) Substituted 7-Amino-5-thio-thiazolo[4, 5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1). Journal of Medicinal Chemistry, 56, 3177-3190. https://doi.org/10.1021/jm3012273
|
[110]
|
Tang, Z., Gan, Y., Liu, Q.Yin, J.-X., Liu, Q., Shi, J. and Shi, F.-D. (2014) CX3CR Deficiency Supresses Activation and Neurotoxicity of Microglia/Macrophage in Experimental Ischemic Stroke. Journal of Inflammation, 11, 26.
|
[111]
|
Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R. and Bacon, K.B. (1999) Characterization of Fractalkine in Rat Brain Cells: Migratory and Activating Signals for CX3CR-1 Expressing Microglia. The Journal of Immunology, 163, 1628-1635.
|
[112]
|
Steen, A., Larsen, O., Thiele, S. and Rosenkilde, M.M. (2014) Biased and G-Protein Independent Signaling of Chemokine Receptors. Frontiers and Immunology, 5, Article 277. https://doi.org/10.3389/fimmu.2014.00277
|
[113]
|
Malmquist, J. and Strom, P. (2012) Multiple Labeling of a Potent CX3CR1 Antagonist for the Treatment of Multiple Sclerosis. Journal of Labelled Compounds and Radiopharmaceuticals, 55, 387-392. https://doi.org/10.1002/jlcr.2958
|
[114]
|
Pomper, M., Mease, R.C., Xing, Y. and Foss, C. (2016) Radiofluorinated 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines for Imaging Fractalkine Receptor (CX3CR1). WO2016200939 A1.
|
[115]
|
Steinfeld, R., Grapp, M., Kraetzner, R., Dreha-Kulaczewski, S., Helms, G., Dechent, P., Wevers, R., Gro, S. and Gartner, J. (2009) Folate Receptor Alpha Defect Causes Cerebral Folate Transport Deficiency: A Treatable Neurodegenerative Disorder Associated with Disturbed Myelin Metabolism. The American Journal of Human Genetics, 85, 354-363. https://doi.org/10.1016/j.ajhg.2009.08.005
|
[116]
|
Doucette, M.M. and Stevens, V.L. (2001) Folate Receptor Function is Regulated in Response to Different Cellular Growth Rates in Cultured Mammalian Cells. Journal of Nutrition, 131, 2819-2825.
|
[117]
|
Yi, J.S. (2016) Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases. Immune Network, 16, 337-343.
https://doi.org/10.4110/in.2016.16.6.337
|
[118]
|
Farkas, R., Siwowska, K., Ametamey, S.M., Schibli, R., van der Meulen, N.P. and Müller C. (2016) 64Cu and 68Ga Based PET Imaging of Folate Receptor Positive Tumors: Development and Evaluation of an Albumin Binding NODAGA-Folate. Molecular Pharmaceutics, 13, 1979-1987.
https://doi.org/10.1021/acs.molpharmaceut.6b00143
|
[119]
|
Han, W., Zaynagetdinov, R., Yull, F.E., Polosukhin, V.V., Gleaves, L.A., Tanjore, H., Young, L.R., Peterson, T.E., Manning, H.C., Prince, L.S. and Blackwell, T.S. (2015) Molecular Imaging of Folate Receptor Positive Macrophages during Acute Lung Inflammation. American Journal of Respiratory Cell and Molecular Biology, 53, 50-59.
|
[120]
|
Puig-Kroger, A., Sierra-Filardi, E., Dominguez Soto, A., Samaniego, R., Corcuera, M.T., Gomez-Aguado, F., Ratnam, M., Sanchez-Mateos, P. and Corbi, A.L. (2009) Folate Receptor β Is Expressed by Tumor Associated Macrophages and Constitutes a Marker for M2 Anti-Inflammatory/Regulatory Macrophages. Cancer Research, 69, 9395-9403. https://doi.org/10.1158/0008-5472.CAN-09-2050
|
[121]
|
Mayanil, C.S., Siddiqui, M.R. and Tomita, T. (2014) Novel Functions of Folate Receptor Alpha in CNS Development and Diseases. Neuroscience Discovery, 2, 5.
http://www.hoajonline.com/journals/pdf/2052-6946-2-5.pdf
|
[122]
|
Boshnjaku, V., Shim, K.-W., Tsurubuchi, T., Ichi, S., Szany, E.V., Xi, G., Mania-Farnell, B., Mclone, D.G., Tomita, T. and Mayanil, C.S. (2012) Nuclear Localization of Folate Receptor Alpha: A New Role as a Transcription Factor. Scientific Reports, 2, 980. https://doi.org/10.1038/srep00980
|
[123]
|
Gordon N. (2009) Cerebral Folate Deficiency. Developmental Medicine and Child Neurology, 51, 180-182. https://doi.org/10.1111/j.1469-8749.2008.03185.x
|
[124]
|
O’Shannessy, D.J., Somers, E.B., Wang, L.-C., Wang, H. and Hsu. R. (2015) Expression of Folate Receptors Alpha and Beta in Normal and Cancerous Gynecologic Tissues: Correlation of Expression of Beta Isoform with Macrophage Markers. Journal of Ovarian Research, 8, 29. https://doi.org/10.1186/s13048-015-0156-0
|
[125]
|
Van der Heijden, V.W., Oerlemans, R., Dijkmans, B.A.C., Qi, H., van der Laken, C.J., Lems, W.F., Jackman, A.L., Kraan, M.C., Tak, P.P., Ratnam, M. and Jansen, G. (2009) Folate Receptor β as a Potential Delivery Route for Novel Folate Antagonists to Macrophages in the Synovial Tissue of Rheumatic Arthritis Patients. Arthritis & Rheumatism, 60, 12-21. https://doi.org/10.1002/art.24219
|
[126]
|
Jager, N.A., Westra, J., Golestani, R., van Dam, G.M., Low, P.S., Tio, R.A., Slart, R.H.J.A., Boersma, H.H., Bijl, M. and Zeebregts, C.J. (2014) Folate Receptor β Imaging Using 99mTc Folate to Explore Distribution of Polarized Macrophage Populations in Human Atherosclerotic Plaque. Journal of Nuclear Medicine, 55, 1945-1951.
https://doi.org/10.2967/jnumed.114.143180
|
[127]
|
Nagayoshi, R., Nagai, T., Matsushit, K., Sato, K., Sunahara, N., Matsuda, T., Nakamura, T., Komiya, S., Onda, M. and Matsuyama, T (2005) Effectiveness of Anti-Folate Receptor-Beta Antibody Conjugated with Truncated Pseudomonas Exotoxin in the Targeting of Rheumatoid Arthritis Synovial Macrophages. Arthritis Rheum, 52, 2666-2675. https://doi.org/10.1002/art.21228
|
[128]
|
Spector, R. and Lorenzo, A.V. (1975) Folate Transport by Choroid Plexus In Vitro. Science, 187, 540-542. https://doi.org/10.1126/science.1167256
|
[129]
|
Ramaekers, V., Sequeira, J.M. and Quadros, E.V. (2013) Clinical Recognition and Aspects of the Cerebral Folate Deficiency Syndromes. Clinical Chemistry and Laboratory Medicine, 51, 497-511. https://doi.org/10.1515/cclm-2012-0543
|
[130]
|
Bettio, A., Honer, M., Müller, C., Brühlmeier, M., Müller, U., Schibli, R., Groehn, V., Schubiger, P.A. and Ametamey, S.M. (2006) Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with 18F for PET Imaging of Folate Receptor Positive Tumors. Journal of Nuclear Medicine, 47, 1153-1160.
|
[131]
|
Schieferstein, H. and Ross, T.L. (2013) 18F-Labeled Folic Acid Derivatives for Imaging of the Folate Receptor via Positron Emission Tomography. Journal of Labelled Compounds and Radiopharmaceuticals, 56, 432-440.
https://doi.org/10.1002/jlcr.3104
|
[132]
|
Ross, T.L., Honer, M., Lam, P.Y., Mindt, T.L., Groehn, V., Schibli, R., Schubiger, P.A. and Ametamey, S.M. (2008) Fluorine-18 Click Radiosynthesis and Preclinical Evaluation of a New 18F-labeled Folic Acid Derivative. Bioconjugate Chemistry, 19, 2462-2470. https://doi.org/10.1021/bc800356r
|
[133]
|
Müller, C. and Schibli, R. (2013) Prospects in Folate Receptor-Targeted Radionuclide Therapy. Frontiers in Oncology, 3, Article 249.
https://doi.org/10.3389/fonc.2013.00249
|
[134]
|
Siwowska, H., Haller, S., Bortoli, F., Benesova, M., Groehn, V., Berhard, P., Schibli, R. and Müller, C. (2017) Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the In Vitro and In Vivo Properties. Molecular Pharmaceutics, 14, 523-532. https://doi.org/10.1021/acs.molpharmaceut.6b01010
|
[135]
|
Fischer, C.R., Muller, C., Reber, J., Muller, A., Kramer, S.D., Ametamey, S.M. and Schibli, R. (2012) [18F]Fluoro-Deoxy-Glucose Folate: A Novel PET Radiotracer with Improved In Vivo Properties for Folate Receptor Targeting. Bioconjugate Chemistry, 23, 805-813. https://doi.org/10.1021/bc200660z
|
[136]
|
Ross, T.L., Honer, M., Muller, C., Groehn, V., Schibli, R. and Ametamey, S.M. (2010) A New 18F-Labeled Folic Acid Derivative with Improved Properties for the PET Imaging of Folate Receptor-Positive Tumors. Journal of Nuclear Medicine, 51, 1756-1762. https://doi.org/10.2967/jnumed.110.079756
|
[137]
|
Pissarek M. (2017) Small Molecule-Assisted Brain PET: Approaches to Imaging of Conformational Diseases. World Journal of Neuroscience, 7, 106-139.
https://doi.org/10.4236/wjns.2017.71010
|
[138]
|
Damont, A., Medran-Navarrete, V., Cacheux, F., Kuhnast, B., Pottier, G., Bernards, N., Marguet, F., Puech, F., Boisgard, R. and Dollé, F. (2015) Novel Pyrazololo[1, 5-a]Pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, In Vitro Biological Evaluation, [18F]-Labeling, and In Vivo Neuroinflammation PET Images. Journal of Medicinal Chemistry, 58, 7449-7464.
https://doi.org/10.1021/acs.jmedchem.5b00932
|
[139]
|
Dupont, A.-C., Largeau, B., Ribeiro, M.J.S., Guilloteau, D., Tronel, C. and Arlicot, N. (2017) Translocator Protein 18 kDa (TSPO) Positron Emission Tomography Imaging (PET) and Its Clinical Impact in Neurodegenerative Diseases. International Journal of Molecular Sciences, 18, 785. https://doi.org/10.3390/ijms18040785
|
[140]
|
Hilmer, A.T., Holden, D., Fowles, K., Nabusi, N., West, B.L., Carson, R.E. and Cosgrove K.P. (2017) Microglial Depletion and Activation. A [11C]PBR28 PET Study in Nonhuman Primates. EJNMMI Research, 7, 59.
http://doi.org/10.1186/s13550-017-0305-0
|
[141]
|
McManus, R.M. and Heneka, M.T. (2017) Role of Neuroinflammation in Neurodegeneration: New Insights. Alzheimer’s Research and Therapy, 9, 14.
https://doi.org/10.1186/s13195-017-0241-2
|
[142]
|
Sheridan, G.K. and Murphy, K.J. (2013) Neuron-Glia Crosstalk in Health and Disease: Fractalkine and CX3CR1 Take Centre Stage. Open Biology, 3, 130181.
http://doi.org/10.1098/rsob.130181
|
[143]
|
Paolicelli, R.C., Bisht, K. and Tremblay, M.-E. (2014) Fractalkine Regulation of Microglial Physiology and Consequences on the Brain and Behavior. Frontiers in Cellular Neuroscience, 8, Article 129. https://doi.org/10.3389/fncel.2014.00129
|